Renown Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 21.50 Cr
as on 09-07-2024
- Paid Up Capital ₹ 16.50 Cr
as on 09-07-2024
- Company Age 19 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.95 Cr
as on 09-07-2024
- Satisfied Charges ₹ 52.86 Cr
as on 09-07-2024
- Revenue 48.55%
(FY 2021)
- Profit 276.52%
(FY 2021)
- Ebitda 109.99%
(FY 2021)
- Net Worth 375.41%
(FY 2021)
- Total Assets 2.83%
(FY 2021)
About Renown Pharmaceuticals
The Corporate was formerly known as Renown Ceratek Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 21.50 Cr and a paid-up capital of Rs 16.50 Cr.
The company currently has active open charges totaling ₹22.95 Cr. The company has closed loans amounting to ₹52.86 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Renown Pharmaceuticals Private Limited India is Scany Parmar as COMPANY SECRETARY. Smita Rameshkumar, Ramesh Jatia, Atishay Ramesh, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ2005PTC046714
- Company No.
046714
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Renown Pharmaceuticals Private Limited offer?
Renown Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Anti Acne Drug, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Ayurvedic Medicine, Herbal Products, Herbal Capsules, Vitamin Tablets & Capsules, Dietary Supplements, Edible Oil & Allied Products.
Who are the key members and board of directors at Renown Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Jatia  | Managing Director | 31-Dec-2009 | Current |
| Scany Parmar | Company Secretary | 01-Oct-2022 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Smita Rameshkumar | Director | 05-Sep-2005 | Current |
| Atishay Ramesh | Director | 28-Sep-2007 | Current |
| Satish Duggappa | Director | 31-Dec-2009 | Current |
Financial Performance of Renown Pharmaceuticals.
Renown Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 48.55% increase. The company also saw a substantial improvement in profitability, with a 276.52% increase in profit. The company's net worth Soared by an impressive increase of 375.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Renown Pharmaceuticals?
In 2021, Renown Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Moran Plantations Pvt. Ltd.Active 33 years 5 daysSmita Rameshkumar and Ramesh Jatia are mutual person
- Glorious Trading Private LimitedActive 17 years 7 months
Smita Rameshkumar, Ramesh Jatia and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 01 Sep 2021 | ₹22.95 Cr | Open |
State Bank Of India Creation Date: 12 Aug 2011 | ₹41.80 Cr | Satisfied |
Shree Vardhaman Sahakari Bank Limited Creation Date: 28 Oct 2010 | ₹7.00 M | Satisfied |
How Many Employees Work at Renown Pharmaceuticals?
Renown Pharmaceuticals has a workforce of 77 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Renown Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renown Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
